These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 768802

  • 21. [Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
    Fedorova NV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):21-4. PubMed ID: 14681961
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Piribedil therapy in Parkinson's disease. Use of the drug in the retard form.
    Mentenopoulos G, Katsarou Z, Bostantjopoulou S, Logothetis J.
    Clin Neuropharmacol; 1989 Feb; 12(1):23-8. PubMed ID: 2713865
    [Abstract] [Full Text] [Related]

  • 24. Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators.
    Melamed E, Bitton V, Zelig O.
    Neurology; 1986 Jan; 36(1):100-3. PubMed ID: 3941762
    [Abstract] [Full Text] [Related]

  • 25. Action of piribedil in Parkinson's disease: I.V. test and oral treatment.
    Emile J, Chanelet J, Truelle JL, Bastard J.
    Adv Neurol; 1975 Jan; 9():409-13. PubMed ID: 1096577
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
    Tsui JK, Ross S, Poulin K, Douglas J, Postnikoff D, Calne S, Woodward W, Calne DB.
    Neurology; 1989 Apr; 39(4):549-52. PubMed ID: 2494567
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK, Sonninen V, Marttila R.
    Adv Exp Med Biol; 1977 Apr; 90():267-75. PubMed ID: 930747
    [Abstract] [Full Text] [Related]

  • 31. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    Libman I, Gawel MJ, Riopelle RJ, Bouchard S.
    Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Hanzal F.
    MMW Munch Med Wochenschr; 1976 May 14; 118(20):653-6. PubMed ID: 818540
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T, Yahr MD.
    Ann Neurol; 1995 Jan 14; 37(1):95-8. PubMed ID: 7818264
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.